Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer-Reference-Cited by-同舟云学术

Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer

Published:2017-11 Issue: Volume:146 Page:72-85
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Yang Qiwei,Wang Ye,Yang Qing,Gao Yi,Duan Xiaopeng,Fu Qingcheng,Chu Chuanmin,Pan Xiuwu,Cui Xingang,Sun Yinghao

Funder

National Natural Science Foundation of China

National Natural Science Foundation of China for Youths

Fund of Institute of translational medicine, SMMU

Shanghai Municipal Commission of Health and Family Planning

Medical Guidance (Chinese and Western Medicine) Science and Technology Support Project

Shanghai Sailing Program

Youth Foundation of Second Military Medical University

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference35 articles.

1. Renal cancer;Capitanio;Lancet,2016

2. Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy;Kroeger;Eur. Urol.,2014

3. Emerging antiangiogenics for renal cancer;Domblides;Expert Opin. Emerg. Drugs,2013

4. Cabozantinib versus everolimus in advanced renal-cell carcinoma;Choueiri;N. Engl. J. Med.,2015

5. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD);Futterer;J. Pharm. Biomed. Anal.,2013

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive metal-based nanomedicines for boosting anti-tumor immunity: Advance, challenge, and perspective;Coordination Chemistry Reviews;2024-10

2. Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression;Journal of Drug Delivery Science and Technology;2024-09

3. Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers;Frontiers in Oncology;2024-08-13

4. Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials;Materials Today Bio;2024-08

5. Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers;Pathology - Research and Practice;2024-07